Department of Life and Nanopharmaceutical Sciences, Graduate School, Kyung Hee University, Seoul 02453, Korea.
Department of Preventive Pharmacy and Toxicology, College of Pharmacy, Kyung Hee University, Seoul 02453, Korea.
Medicina (Kaunas). 2020 Dec 10;56(12):685. doi: 10.3390/medicina56120685.
var. (CZ), which has traditionally been used as a oriental tea in Asia, is known to have anti-inflammatory effects in osteoarthritis (OA). But the mechanism of these effects has not been made clear and it needs to be elucidated specifically for the clinical use of CZE in OA. To reveal this mechanism, we first identified which biomarkers were expressed in the joints of rats in which OA had been induced with monosodium iodoacetate and determined whether CZ extract (CZE) could normalize these biomarkers in the progression of OA. The anti-osteoarthritis effect of CZE was evaluated for its capability to inhibit levels of extracellular matrix (ECM)-degrading enzymes and enhance ECM synthesis. We also sought to identify whether the marker compound of CZE, linarin, has anti-osteoarthritic effects in the human chondrosarcoma cell line SW1353. The changes in matrix metalloproteinases (MMPs) were remarkable: among them, MMP-1, MMP-3, MMP-9 and MMP-13 were most strongly induced, whereas their expressions were inhibited by CZE dose dependently. The expressions of the ECM synthetic genes, and , and the transcription factor SOX9 of these genes were reduced by OA induction and significantly normalized by CZE dose dependently. SOX9 is also a repressor of ECM-degrading aggrecanases, ADAMTS-4 and ADAMTS-5, and CZE significantly reduced the levels of these enzymes dose dependently. Similar results were obtained using the human chondrosarcoma cell line SW1353 with linarin, the biologically active compound of CZE. These anti-osteoarthritic effects suggest that CZE has mechanisms for activating ECM synthesis with SOX9 as well as inhibiting articular ECM-degrading enzymes.
变种(CZ),在亚洲传统上被用作东方茶,已知具有抗炎作用在骨关节炎(OA)中。但这些作用的机制尚未明确,需要具体阐明 CZE 在 OA 中的临床应用。为了揭示这种机制,我们首先确定了在碘乙酸单钠诱导的 OA 大鼠关节中表达的生物标志物,以及 CZ 提取物(CZE)是否可以在 OA 的进展中使这些生物标志物正常化。通过抑制细胞外基质(ECM)降解酶的水平和增强 ECM 合成来评估 CZE 的抗骨关节炎作用。我们还试图确定 CZE 的标记化合物,滨蒿内酯,在人软骨肉瘤细胞系 SW1353 中是否具有抗骨关节炎作用。基质金属蛋白酶(MMPs)的变化非常显著:其中,MMP-1、MMP-3、MMP-9 和 MMP-13 的诱导作用最强,而 CZE 则依赖剂量抑制其表达。OA 诱导后 ECM 合成基因和的表达减少,这些基因的转录因子 SOX9 也减少,而 CZE 则依赖剂量依赖性地显著正常化。SOX9 也是 ECM 降解 aggrecanases 的抑制剂,ADAMTS-4 和 ADAMTS-5,CZE 也显著依赖剂量降低这些酶的水平。使用 CZE 的生物活性化合物滨蒿内酯的人软骨肉瘤细胞系 SW1353 也获得了类似的结果。这些抗骨关节炎作用表明 CZE 具有通过 SOX9 激活 ECM 合成以及抑制关节 ECM 降解酶的机制。